Sandplay therapy is a nonverbal, multisensory, psychodynamic treatment method for children and adults. With roots in play therapy, the theories of C. G. Jung, and Eastern contemplative practices, sandplay has been growing in popularity worldwide. Research has shown sandplay to be effective in reducing anxiety as measured by rating scales that focus on clinical symptoms.
A recent article in the International Journal of Play Therapyopens in new window by Mariana Foo, Lorraine Freedle, Riryn Sani, and Grace Fonda assesses the effect of sandplay therapy on symptoms and brain metabolite changes in the thalamus of a 23-year-old female patient with general anxiety disorder (GAD). What’s new about this study is that it explores whether the improvement in clinical symptoms from the use of sandplay therapy also involves neurophysiological change.
This single-case study looks at symptom improvement using the Hamilton Anxiety Rating and General Anxiety-7 scales. Building on prior studies that used neuroimaging to examine GAD, the authors used proton magnetic resonance spectroscopy to measure brain metabolites with a particular focus on the ratio of N-Acetylaspartate to creatine—a measure of how well neurons in the brain are able to function.
Along with the therapeutic relationship, the multisensory aspects of sandplay therapy are an important and underlying mechanism for change. The authors chose the thalamus as the targeted brain region of this study because it has an essential role in processing sensory input. It also has interconnections with the amygdala and the limbic system, which are known to be implicated in GAD.
The study began with a 45-day wait to establish the baseline. Next, the 23-year-old participant received 18 one-hour sessions of sandplay therapy over 9 weeks conducted by a qualified sandplay therapist. Her anxiety showed no improvement during the waiting period; however, after treatment with sandplay therapy, her symptoms on both anxiety scales dropped from the severe range to the normal range. Imaging showed that the participant’s ratios of N-Acetylaspartate to creatine in both the right and left thalamus were below the healthy range during the baseline period and increased to within the normal range after treatment. It is possible that sandplay not only reduces clinical symptoms of GAD but also promotes brain health and function, particularly in subcortical systems.
The authors were particularly interested in subcortical brain systems, because these systems not only regulate safety, sensory input, and the stress response but also play a critical role in supporting the “thinking brain.” People with GAD may experience both clinical and neurophysiological improvement with sandplay therapy that could affect how they think, feel, and react to stressors in their lives. More research is needed and is currently underway.
Note: This article is in the Clinical Psychology topic area. View more articles in the Clinical Psychology topic area.

